title: The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm.
abstract: Gastroenteropancreatic neuroendocrine tumors (NETs) often present as liver metastasis from a carcinoma of unknown primary. We recently showed that primary NETs from the pancreas, small intestine and stomach as well as their respective liver metastases differ from each other by the expression profile of the three genes CD302, PPWD1 and ABHB14B. The gene and protein expression of CD302, PPWD1, and ABHB14B was studied in abdominal NET metastases to identify the site of the respective primary tumors. Cryopreserved tissue from NET metastases collected in different institutions (group A: 29, group B: 50, group C: 132 specimens) were examined by comparative genomic hybridization (Agilent 105 K), gene expression analysis (Agilent 44 K) (groups A and B) and immunohistochemistry (group C). The data were blindly evaluated, i.e. without knowing the site of the primary. Gene expression analysis correctly revealed the primary in the ileum in 94 % of the cases of group A and in 58 % of group B. A pancreatic primary was predicted in 83 % (group A) and 20 % (group B), respectively. The combined sensitivity of group A and B was 75 % for ileal NETs and 38 % for pancreatic NETs. Immunohistochemical analysis of group C revealed an overall sensitivity of 80 %. Gene and protein expression analysis of CD302 and PPWD1 in NET metastases correctly identifies the primary in the pancreas or the ileum in 80 % of the cases, provided that the tissue is well preserved. Immunohistochemical profiling revealed CD302 as the best marker for ileal and PPWD1 for pancreatic detection.
authors.affiliation: Department of General and Visceral Surgery, Zentralklinik Bad Berka, Robert-Koch-Allee 9, 99437, Bad Berka, Germany, Daniel.Kaemmerer@zentralklinik.de.
authors.forename: D
authors.initials: D
authors.lastname: Kaemmerer
authors.forename: N
authors.initials: N
authors.lastname: Posorski
authors.forename: F
authors.initials: F
authors.lastname: von Eggeling
authors.forename: G
authors.initials: G
authors.lastname: Ernst
authors.forename: D
authors.initials: D
authors.lastname: Hörsch
authors.forename: R P
authors.initials: RP
authors.lastname: Baum
authors.forename: V
authors.initials: V
authors.lastname: Prasad
authors.forename: R
authors.initials: R
authors.lastname: Langer
authors.forename: I
authors.initials: I
authors.lastname: Esposito
authors.forename: G
authors.initials: G
authors.lastname: Klöppel
authors.forename: S
authors.initials: S
authors.lastname: Sehner
authors.forename: T
authors.initials: T
authors.lastname: Knösel
authors.forename: M
authors.initials: M
authors.lastname: Hommann
mesh_terms: D004702:Endocrine Glands / Q000473:pathology*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000235:genetics / Q000473:pathology*
references.citation: J Pathol. 2001 Sep;195(1):72-9
references.pmid: 11568893
references.citation: J Natl Compr Canc Netw. 2011 Dec;9(12):1358-95
references.pmid: 22157556
references.citation: J Cancer Res Clin Oncol. 2012 Mar;138(3):397-403
references.pmid: 22160160
references.citation: J Pathol. 2001 Sep;195(1):41-52
references.pmid: 11568890
references.citation: PLoS One. 2008;3(12):e3767
references.pmid: 19048101
references.citation: Cancer Res. 2004 Jun 15;64(12):4099-104
references.pmid: 15205318
references.citation: J Clin Oncol. 2008 Sep 20;26(27):4435-41
references.pmid: 18802156
references.citation: PLoS One. 2013;8(1):e53406
references.pmid: 23308215
references.citation: Zentralbl Chir. 2014 Jun;139(3):284-91
references.pmid: 23508839
references.citation: Semin Oncol. 2010 Apr;37(2):71-9
references.pmid: 20494696
references.citation: Semin Nucl Med. 2012 May;42(3):190-207
references.pmid: 22475428
references.citation: Recent Results Cancer Res. 2008;170:225-42
references.pmid: 18019630
references.citation: Ann Oncol. 2010 Oct;21 Suppl 7:vii303-7
references.pmid: 20943633
references.citation: Nat Med. 2008 Aug;14(8):822-7
references.pmid: 18641660
references.citation: Endocr Relat Cancer. 2006 Jun;13(2):541-58
references.pmid: 16728581
references.citation: Cancer Treat Rev. 2011 Aug;37(5):358-65
references.pmid: 21481536
references.citation: Cancer Res. 2001 Oct 15;61(20):7388-93
references.pmid: 11606367
references.citation: Clin Exp Metastasis. 2011 Oct;28(7):637-47
references.pmid: 21681495
references.citation: Am J Surg Pathol. 2012 May;36(5):737-43
references.pmid: 22498824
references.citation: Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15149-54
references.pmid: 11742071
references.citation: Am J Pathol. 2001 Oct;159(4):1231-8
references.pmid: 11583950
references.citation: J Clin Oncol. 2013 Jan 10;31(2):217-23
references.pmid: 23032625
references.citation: Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):67-77
references.pmid: 19618183
references.citation: Laryngoscope. 2012 Jun;122(6):1279-82
references.pmid: 22538837
references.citation: Nucl Med Commun. 2004 May;25(5):445-9
references.pmid: 15100502
references.citation: Br J Cancer. 2008 Apr 22;98(8):1425-30
references.pmid: 18414470
references.citation: Mol Cell Proteomics. 2003 Jul;2(7):443-52
references.pmid: 12824440
references.citation: Mod Pathol. 2013 Jul;26(7):995-1003
references.pmid: 23503646
references.citation: Eur J Nucl Med Mol Imaging. 2012 Aug;39(8):1278-83
references.pmid: 22584487